Powell's warning, Micron earnings, 'financial nihilism' and more in Morning Squawk

Federal Reserve Chair Jerome Powell justified the recent rate cut by citing a cooling labor market, while acknowledging a challenging economic path and describing equities as 'fairly highly valued' without elevated financial stability risks, which prompted a market dip. In corporate developments, OpenAI is committing hundreds of billions to AI infrastructure, and Eli Lilly announced a $6.5 billion manufacturing facility for drug production. Micron Technology reported strong Q4 results with 46% revenue growth driven by AI demand, yet its stock saw a muted post-earnings reaction after a significant year-to-date rally. Additionally, a proposed $100,000 H-1B visa fee is expected to severely impact tech startups, and a trend of 'financial nihilism' is driving younger investors towards riskier assets.

Analysis

Federal Reserve Chair Jerome Powell's recent comments introduce a cautious tone to the market, attributing the latest interest rate cut to a cooling labor market while simultaneously warning of a "challenging situation" and describing equity valuations as "fairly highly valued." This guidance prompted an immediate market downturn, snapping the S&P 500's three-day record streak and suggesting that monetary easing may not be a straightforward catalyst for further gains. In contrast to this macro uncertainty, corporate-level activity in high-growth sectors remains robust. Micron Technology (MU) reported a 46% year-over-year revenue surge driven by AI demand, yet its stock's muted reaction highlights that its near-doubling in 2025 may have already priced in such performance. Similarly, massive capital commitments from OpenAI ($850 billion total) and Eli Lilly ($6.5 billion for a new facility) underscore a long-term investment cycle in AI and pharmaceuticals, with Lilly's move aimed at scaling production for its high-demand experimental obesity drug, orforglipron. However, new headwinds are emerging, notably a proposed $100,000 H-1B visa fee that threatens to severely hamper talent acquisition for tech startups. Concurrently, a trend of "financial nihilism" among younger investors is channeling capital into more speculative assets, indicating a pocket of retail sentiment driven by short-term risk-taking rather than long-term fundamentals.

Key Decisions for Investors

• Given the Fed's cautious outlook and description of equities as 'fairly highly valued', investors should re-evaluate exposure to high-beta assets and prepare for potential market consolidation following recent record highs.
• For stocks like Micron that have seen significant appreciation, it is crucial to scrutinize valuations, as the muted post-earnings reaction despite a 46% revenue surge indicates that optimistic AI-driven results may already be fully priced in.
• Eli Lilly's $6.5 billion manufacturing investment signals strong management confidence in its obesity drug pipeline; long-term investors may view this as a positive catalyst for de-risking future production and capturing market share.
• Monitor the proposed $100,000 H-1B visa fee as a key risk factor for the US technology sector, as it could disproportionately impact the growth prospects of smaller, innovation-driven companies and favor large incumbents with offshore capabilities.